Transforming Genetic Medicine & Genome Engineering with AI

3D rendering X chromosome

Genetic Medicine

Develop genetic medicines—safer, smarter, faster—for patients

Doctor cutting DNA molecule and check with analysis chromosome DNA genetic of human with ai virtual interface
How We Can Help

Vector & Payload Design

FORMsightAI optimizes AAV vector genomes and large/complex payloads, improving integrity, reducing truncations, and enabling tunable expression.

AI-Powered Accuracy

AI-augmented CDS optimization and rational design enhance manufacturability, lower safety risks, and reduce CpG-driven immunogenicity.

Maximizing Efficacy

Expression tuning and codon optimization improve CAR-T persistence and potency, enabling safer and more effective therapies.

Scalable Manufacturing

Demonstrated up to 5x improvements in genome integrity and 4.4x yield gains, directly lowering COGS and supporting efficient clinical translation.

Pipeline

Transforming the genetic medicine pipeline from concept to clinic with AI‑driven design and analysis

Indication
Partner
Discovery
Preclinical
IND
Clinical
Duchenne Muscular Dystrophy
Cure Rare Disease logo
Discovery
Preclinical
IND
Clinical
Alzheimer’s Disease
Weill Cornell Medicine
Discovery
Preclinical
IND
Clinical

Genome Engineering

The company Colossal Biosciences trusts to advance its genome engineering programs

How We Can Help

Next-Gen Editing Tools

Leverage breakthroughs in CRISPR and emerging genome engineering technologies to design and optimize precise genetic modifications in any genome.

AI-Powered Analysis

Combine AI-driven insights with expert biological interpretation to identify and validate key genotype-to-phenotype relationships to engineer desired traits.

Accelerate Validation

Validation analysis using amplicon or whole-genome sequencing to measure on-target efficiency and predict impactful off-target effects.

Colossal Dire Wolf / Age: 5 month

Applications

Genome Integrity Analysis

A clear, structured approach for characterizing genetic medicine

Drug Product Insights

Gain a clear view of what’s encapsidated— distribution of full vs. partial genomes and contaminated species. 

Design Recommendations

Assess feasibility and computational rational design to select top-ranked vectors optimized for manufacturability.

Get Started
Genome Integrity Analysis illustration

Codon Optimization

An innovative AI technology for reaching effective genetic sequences

Define Program Objectives

Clarify biological goals for optimization, such as boosting protein expression, enhancing manufacturability, and improving safety.

Balancing Tradeoffs

Our model aligns with your goals, optimizing across multiple objectives while managing tradeoffs like increasing expression vs. minimizing truncations.

Optimization & Insights

Leverage Form Bio’s proprietary FORMsightAI model to optimize designs and identify codon substitutions that drive desirable outcomes.

Get Started
Codon Optimization illustration

Genome Assembly

Accurate reconstruction of genomes to drive discovery in genetics and biology

Genome Reconstruction

Piece together DNA fragments into accurate, contiguous sequences. 

Downstream Insights

High quality assemblies that support variant detection, functional annotation, and comparative genomics. 

Get Started
Genome Assembly illustration
“Computer-aided design, fabrication, testing analysis & ML are key to the future of bioengineering . . . Form Bio is critical to pave the way.”
George Church, PhD
George Church, PhD
Professor, Harvard Medical School & MIT; Director of Synthetic Biology, The Wyss Institute
“Form Bio supports [Taysha’s] goals by providing us the data infrastructure support & analysis to be able to test samples in a streamlined way…”
Frederick Porter, PHD
Frederick Porter, PhD
Chief Technology Officer, 
Taysha Gene Therapies
“Form Bio helps support [Solid’s] goals by allowing us to bring new therapeutics faster through an accelerated timeline to the clinic…”
Paul Herzich
Paul Herzich
Chief Technology Officer, 
Solid Biosciences
About Form Bio

Form Bio, the first spinout from Colossal Biosciences (2022), expands foundational multi-species genome engineering technology into human genetic medicines.

We are AI and software engineers, bioinformaticians, molecular and cellular biologists, and drug developers dedicated to accelerating genetic medicine and unlocking breakthroughs that transform health and improve lives.

Time magazine cover

Leadership Team

Michelle Chen, PhD

Michelle Chen, PhD

CEO
Doug Daniels

Doug Daniels

CTO
Joe Nipko, PhD

Joe Nipko, PhD

VP, AI
Amicia Elliott, PhD

Amicia Elliott, PhD

VP, Product
Dan Shiffman

Dan Shiffman

Interim Head of Sales
Angela Anderson

Angela Anderson

Head of Marketing
Christina Capehart

Christina Capehart

VP, HR & People Operations

Let’s Unlock the Next Breakthrough Together

Contact Us